Céline Loriot
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
-
- Pituitary Gland Disorders and Treatments
- Hormonal Regulation and Hypertension
Papers in
- Co-authors
- Judith Favier (5 shared papers)Anne‐Paule Gimenez‐Roqueplo (5 shared papers)Laurence Amar (4 shared papers)Jérôme Bertherat (4 shared papers)Éric Letouzé (4 shared papers)Nelly Burnichon (3 shared papers)Nasséra Abermil (2 shared papers)Alexandre Buffet (2 shared papers)
- Journals
- Oncotarget (2 papers)The Journal of Clinical Endocrinology & Metabolism (1 paper)Human Molecular Genetics (1 paper)American Journal Of Pathology (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Céline Loriot
9 papers receiving 1.1k citations
Céline Loriot's Hit Papers
Peers
Comparison fields: 5 of 68
- Cancer Research 615
- Endocrinology, Diabetes and Metabolism 285
- Surgery 504
- Genetics 103
- Neurology 99
Countries citing papers authored by Céline Loriot
This map shows the geographic impact of Céline Loriot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Loriot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Loriot more than expected).
Fields of papers citing papers by Céline Loriot
This network shows the impact of papers produced by Céline Loriot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Loriot. The network helps show where Céline Loriot may publish in the future.
Co-authors
The 25 scholars most cited alongside Céline Loriot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma Hit paper breakdown → | 2013 | 583 |
| 2 | 2014 | 151 | |
| 3 | 2012 | 114 | |
| 4 | 2012 | 87 | |
| 5 | 2015 | 58 | |
| 6 | 2011 | 48 | |
| 7 | 2021 | 36 | |
| 8 | 2017 | 21 | |
| 9 | 2017 | 1 |
About Céline Loriot
Céline Loriot is a scholar working on Surgery, Oncology, Cancer Research, Genetics and Neurology, having authored 9 papers that have together received 1.1k indexed citations. Recurring topics across this work include Adrenal and Paraganglionic Tumors (4 papers), Neuroblastoma Research and Treatments (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), Lung Cancer Research Studies (1 paper), DNA Repair Mechanisms (1 paper), Neurofibromatosis and Schwannoma Cases (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Cancer Research (615 citations), Endocrinology, Diabetes and Metabolism (285 citations), Surgery (504 citations), Genetics (103 citations) and Neurology (99 citations). Céline Loriot has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Judith Favier, Anne‐Paule Gimenez‐Roqueplo, Laurence Amar, Jérôme Bertherat, Éric Letouzé, Nelly Burnichon, Nasséra Abermil, Alexandre Buffet, Cosimo Martinelli and Mélanie Menara. Their work appears in journals such as Oncotarget, The Journal of Clinical Endocrinology & Metabolism, Human Molecular Genetics, American Journal Of Pathology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.